Skip to content

Clinical trials

Phase 2 Neuralgia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuralgia Phase: Phase 2 Country / region: United States Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20022
20031
20051
20062
20074
20086
20094
20102
20113
20126
20133
20142
20162
20172
20182
20192
20202
20211
20222
20232
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38
Terminated14
Withdrawn3
Recruiting3
Unknown status2
Suspended1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Dental and Craniofacial Research (NIDCR)3
Virginia Commonwealth University3
XenoPort, Inc.3
AbbVie (prior sponsor, Abbott)2
AstraZeneca2
GlaxoSmithKline2
Icahn School of Medicine at Mount Sinai2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
NeurogesX2
Pfizer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuralgia62
Pain17
Neuralgia, Postherpetic13
Diabetic Neuropathies11
Herpes Zoster10
Agnosia8
Peripheral Nervous System Diseases8
Diabetes Mellitus5
Chronic Pain4
Hyperalgesia4

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.